Mast cell tryptase changes with Aspergillus fumigatus - Host crosstalk in cystic fibrosis patients

被引:3
|
作者
Gomez, Carine [1 ,2 ]
Carsin, Ania [3 ]
Gouitaa, Marion [4 ]
Reynaud-Gaubert, Martine [1 ,2 ]
Dubus, Jean-Christophe [2 ,3 ]
Mege, Jean-Louis [2 ]
Ranque, Stephane [2 ]
Vitte, Joana [2 ]
机构
[1] Aix Marseille Univ, Hop Nord, AP HM, Ctr Ressources & Competences Mucoviscidose, Marseille, France
[2] Aix Marseille Univ, IRD, IHU Mediterranee Infect, MEPHI, Marseille, France
[3] Aix Marseille Univ, Hop Timone Enfants, AP HM, Ctr Ressources & Competences Mucoviscidose,Pneumo, Marseille, France
[4] Aix Marseille Univ, Hop Nord, AP HM, Serv Pneumol, Marseille, France
关键词
Aspergillus fumigatus; Cystic fibrosis; Immunoglobulin E; Lung transplantation; Mast cell tryptase; CHYMASE; SENSITIZATION; INFLAMMATION; DISEASE;
D O I
10.1016/j.jcf.2018.01.012
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pulmonary and systemic antifungal immunity influences quality of life and survival of people with cystic fibrosis. Aspergillus fumigatus (Af) induces specific IgG and IgE. Mast cells respond to IgE, IgG and direct interactions with Af. Mast cells are the source of the protease tryptase. We aimed at evaluating serum baseline tryptase as a potential biomarker of the Af-host interaction in cystic fibrosis patients. Serum baseline tryptase, IgE and IgG directed to Af extract and Af molecular allergens were measured in 76 cystic fibrosis patients. The main findings were (i) lower levels of serum baseline tryptase in patients displaying specific IgE to Af (p < 0.0001) and (ii) an association between tryptase levels and IgE or IgG responses to Af and ribotoxin (Asp f 1). These findings suggest that serum baseline tryptase is influenced by Af-host interactions and thus might be a marker for mast cell regulation and pulmonary immune defenses. (C) 2018 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:631 / 635
页数:5
相关论文
共 50 条
  • [11] Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
    Zhao, Jingming
    Yu, Wencheng
    PEERJ, 2018, 6
  • [12] Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?
    de Vrankrijker, A. M. M.
    van der Ent, C. K.
    van Berkhout, F. T.
    Stellato, R. K.
    Willems, R. J. L.
    Bonten, M. J. M.
    Wolfs, T. F. W.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (09) : 1381 - 1386
  • [13] Infection Dynamics of Aspergillus fumigatus in Adults with Cystic Fibrosis (CF)
    Moore, John E.
    Rendall, Jacqueline C.
    Millar, Beverley C.
    MYCOPATHOLOGIA, 2023, 188 (05) : 699 - 704
  • [14] Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis
    Nicole Ritz
    Roland A. Ammann
    Carmen Casaulta Aebischer
    Franziska Schoeni-Affolter
    Martin H. Schoeni
    European Journal of Pediatrics, 2006, 165 : 670 - 670
  • [15] Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis
    Ritz, N
    Ammann, RA
    Casaulta Aebischer, C
    Schoeni-Affolter, F
    Schoeni, MH
    EUROPEAN JOURNAL OF PEDIATRICS, 2005, 164 (09) : 577 - 582
  • [16] Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis
    Bakare, N
    Rickerts, V
    Bargon, J
    Just-Nübling, G
    MYCOSES, 2003, 46 (1-2) : 19 - 23
  • [17] Molecular typing and colonization patterns of Aspergillus fumigatus in patients with cystic fibrosis
    de Valk, Hanneke A.
    Klaassen, Corne H. W.
    Yntema, Jan-Bart
    Hebestreit, Alexandra
    Seidler, Marc
    Haase, Gerhard
    Mueller, Frank-Michael
    Meis, Jacques F. G. M.
    JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (02) : 110 - 114
  • [18] Azole Resistance in Aspergillus fumigatus in Patients with Cystic Fibrosis: A Matter of Concern?
    A. Hamprecht
    F. Morio
    O. Bader
    P. Le Pape
    J. Steinmann
    E. Dannaoui
    Mycopathologia, 2018, 183 : 151 - 160
  • [19] ANTIBODY-RESPONSES TO ASPERGILLUS-FUMIGATUS ALLERGENS IN PATIENTS WITH CYSTIC-FIBROSIS
    ARRUDA, LK
    MUIR, A
    VAILES, LD
    SELDEN, RF
    PLATTSMILLS, TAE
    CHAPMAN, MD
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 410 - 411
  • [20] The cystic fibrosis treatment Trikafta affects the growth, viability, and cell wall of Aspergillus fumigatus biofilms
    Jones, Jane T.
    Morelli, Kaesi A.
    Vesely, Elisa M.
    Puerner, Charles T. S.
    Pavuluri, Chetan K.
    Ross, Brandon S.
    van Rhijn, Norman
    Bromley, Michael J.
    Cramer, Robert A.
    MBIO, 2023, 14 (05):